Anixa Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Anixa Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Anixa Biosciences Inc
Rating: 1.46641675
Author: Trendlyne DVM scores

about

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, ...

3.16 0.06 (1.94%)

52.66% Gain from 52W Low

87,717

XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

3.7 / 100

Technically Neutral

55.0 / 100

1Yr Price target upside is 169%

2 analysts

Anixa Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Anixa Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, ...

52.66% Gain from 52W Low

SWOT Analysis

Anixa Biosciences Inc Live Price Chart